The Trigger in IVF Cycles: Molecular Pathways and Clinical Implications
International Journal of Molecular Sciences · 11.12.2025 · 26 (24) · 11962
DOI: 10.3390/ijms262411962 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.12.2025. Verfasst von Giorgio Maria Baldini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", 70121 Bari, Italy. Hauptthemen laut MEDLINE: Fertilization in Vitro, Ovulation Induction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The final trigger of oocyte maturation is a pivotal step in assisted reproductive technology (ART). Different molecules and protocols—including human chorionic gonadotropin (hCG), gonadotropin-releasing hormone agonists (GnRHa), the dual trigger, the double trigger, and emerging agents such as kisspeptin—have been investigated to optimize oocyte competence, embryo development, and pregnancy outcomes while minimizing the risk of ovarian hyperstimulation syndrome (OHSS). HCG remains the most widely used trigger, but its pharmacological profile is associated with a significant risk of OHSS. GnRHa has emerged as an alternative in antagonist cycles, abolishing the risk of severe OHSS but often requiring tailored luteal phase support. Several strategies, including hCG, GnRHa, and combined approaches, have shown improvements in specific outcomes such as the oocyte maturity (MII) rate, fertilization rate, embryo development parameters, and, in selected contexts, a reduction in OHSS risk. Kisspeptin represents a promising option; however, its use remains predominantly within the research setting, with clinical application still limited to early-phase or highly selected studies. Beyond the choice of molecule, the timing of trigger administration—adjusted to follicle size, estradiol concentrations, and progesterone levels—also influences oocyte competence and subsequent clinical outcomes. Triggering final oocyte maturation remains a multifaceted decision that should be individualized according to patient characteristics, ovarian response, and risk of OHSS. Although hCG remains the historical reference standard, accumulating but heterogeneous evidence suggests that GnRHa-based strategies, including dual-trigger protocols, may improve specific outcomes in selected patient subgroups. However, results across trials are inconsistent, particularly in poor responders, and any exposure to hCG maintains a residual risk of OHSS. Kisspeptin represents a promising but still experimental option, with current data largely limited to early-phase clinical studies in highly selected high-risk populations. Well-designed randomized trials are required to clarify the true impact of these strategies on live birth, to refine timing and dosing, and to better define which patients are most likely to benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obstetrics and Gynecology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", 70121 Bari, Italy.
- IVF Center, Momo Fertilife, 76011 Bisceglie, Italy.
- Department of Chemistry, Biology and Biotechnologies, University of Perugia, Via dell' Elce di Sotto 8, 06132 Perugia, Italy.
- Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
- Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel HaShomer, Ramat Gan 5262000, Israel.
ORCID-Profile: Giorgio Maria Baldini, Domenico Baldini, Daniele Ferri, Maria Matteo, Raoul Orvieto
Zitieren
APA
Baldini, G. M., Baldini, D., Lot, D., Ferri, D., Malvasi, A., Fioretti, B., Matteo, M., & Orvieto, R. (2025). The Trigger in IVF Cycles: Molecular Pathways and Clinical Implications. International Journal of Molecular Sciences, 26(24), 11962. https://doi.org/10.3390/ijms262411962
Vancouver
Baldini GM, Baldini D, Lot D, Ferri D, Malvasi A, Fioretti B, et al. The Trigger in IVF Cycles: Molecular Pathways and Clinical Implications. International Journal of Molecular Sciences. 2025;26(24):11962. doi:10.3390/ijms262411962
BibTeX
@article{Baldini2025,
author = {Baldini, Giorgio Maria and Baldini, Domenico and Lot, Dario and Ferri, Daniele and Malvasi, Antonio and Fioretti, Bernard and Matteo, Maria and Orvieto, Raoul},
title = {The Trigger in IVF Cycles: Molecular Pathways and Clinical Implications},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {24},
pages = {11962},
doi = {10.3390/ijms262411962}
}
EUVIMED